Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.01B
sum of reported positions
Reported positions
489
Changes vs prior quarter
492
132 new · 79 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 155 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.45M | $691M | 8.6% | |
TEVA PHARMACEUTICAL INDS LTD | 12.5M | $412M | 5.1% |
| 1.37M | $397M | 5.0% | |
| 1.1M | $394M | 4.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.52B | $8.01B |
| Positions | 436 | 489 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 9% |
| 1.95M |
| $391M |
| 4.9% |
| 1.63M | $389M | 4.9% |
| 484K | $367M | 4.6% |
| 3.91M | $345M | 4.3% |
| 1.94M | $228M | 2.8% |
| 590K | $209M | 2.6% |
| 1.17M | $171M | 2.1% |
| 1.8M | $164M | 2.1% |
| 2.24M | $161M | 2.0% |
| 390K | $155M | 1.9% |
| 2.65M | $151M | 1.9% |
| 519K | $146M | 1.8% |
| 757K | $140M | 1.7% |
| 1.63M | $135M | 1.7% |
| 1.34M | $128M | 1.6% |
| 1.41M | $123M | 1.5% |
| 1.14M | $121M | 1.5% |
| 24M | $120M | 1.5% |
| 360K | $118M | 1.5% |
| 667K | $113M | 1.4% |
| 610K | $99.8M | 1.2% |
Western Union (WU)
1 → 4,600 shares (+459900%)
Lululemon Athletica (LULU)
24 → 309 shares (+1188%)
Synchrony Financial (SYF)
419 → 453 shares (+8%)
Charter Communications (CHTR)
166 → 242 shares (+46%)
LKQ Corporation (LKQ)
1,129 → 1,276 shares (+13%)
Comcast (CMCSA)
1,208 → 1,346 shares (+11%)
Johnson & Johnson (JNJ)
17 → 126 shares (+641%)
Lithia Motors (LAD)
102 → 110 shares (+8%)
UGI Corp (UGI)
880 → 922 shares (+5%)
ADT Inc. (ADT)
4,070 → 4,796 shares (+18%)
Pilgrim's Pride (PPC)
851 → 1,096 shares (+29%)
Ingredion (INGR)
304 → 321 shares (+6%)
Fiserv (FISV)
495 → 607 shares (+23%)
AT&T (T)
1,309 → 1,422 shares (+9%)
Perion Network (PERI)
1 → 3,000 shares (+299900%)
Cormedix (CRMD)
48 → 772 shares (+1508%)
AKAMAI TECHNOLOGIES INC
14 → 51 shares (+264%)
American International Group (AIG)
10 → 300 shares (+2900%)
UnitedHealth (UNH)
1 → 51 shares (+5000%)
Fortinet (FTNT)
30 → 135 shares (+350%)
Ultra Clean Holdings, Inc. (UCTT)
10 → 3,600 shares (+35900%)
Ares Management (ARES)
80 → 181 shares (+126%)
Merck (MRK)
36 → 135 shares (+275%)
Goldman Sachs Bdc (GSBD)
100 → 1,800 shares (+1700%)
TE Connectivity (TEL)
11 → 73 shares (+564%)